Exact Mass: 554.3971034
Exact Mass Matches: 554.3971034
Found 284 metabolites which its exact mass value is equals to given mass value 554.3971034
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ganoderic acid Me
Ganodermic acid S is found in mushrooms. Ganodermic acid S is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Ganoderic acid Me is found in mushrooms.
Ganoderic acid R
Ganoderic acid R is found in mushrooms. Ganoderic acid R is a constituent of cultured mycelium of Ganoderma lucidum (reishi) Constituent of cultured mycelium of Ganoderma lucidum (reishi). Ganoderic acid R is found in mushrooms.
(2xi,3xi)-2,3-Dihydroxy-12,18-ursadien-28-oic acid diacetate
(2xi,3xi)-2,3-Dihydroxy-12,18-ursadien-28-oic acid diacetate is found in pomes. (2xi,3xi)-2,3-Dihydroxy-12,18-ursadien-28-oic acid diacetate is a constituent of Pyrus communis (pear). Constituent of Pyrus communis (pear). (2xi,3xi)-2,3-Dihydroxy-12,18-ursadien-28-oic acid diacetate is found in pomes.
Epoxomicin
(6-Isocyanatohexyl)carbamic acid 3beta-cholesteryl ester
DG(10:0/5-iso PGF2VI/0:0)
DG(10:0/5-iso PGF2VI/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/5-iso PGF2VI/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(5-iso PGF2VI/10:0/0:0)
DG(5-iso PGF2VI/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(5-iso PGF2VI/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/5-iso PGF2VI)
DG(10:0/0:0/5-iso PGF2VI) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(5-iso PGF2VI/0:0/10:0)
DG(5-iso PGF2VI/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/PGF2alpha/0:0)
DG(8:0/PGF2alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGF2alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGF2alpha/8:0/0:0)
DG(PGF2alpha/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGF2alpha/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/PGF2alpha)
DG(8:0/0:0/PGF2alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGF2alpha/0:0/8:0)
DG(PGF2alpha/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/PGE1/0:0)
DG(8:0/PGE1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGE1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGE1/8:0/0:0)
DG(PGE1/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE1/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/PGE1)
DG(8:0/0:0/PGE1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGE1/0:0/8:0)
DG(PGE1/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/PGD1/0:0)
DG(8:0/PGD1/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGD1/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGD1/8:0/0:0)
DG(PGD1/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD1/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/PGD1)
DG(8:0/0:0/PGD1) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGD1/0:0/8:0)
DG(PGD1/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Ganodermic acid S
Di-Ac-(2alpha,3alpha)-2,3-Dihydroxy-5,12-oleanadien-28-oic acid
(13Z,15E,17E)-3beta,28-diacetoxy-22-hydroxymalabarica-13,15,17,24-tetraen-12-one
22-Angeloyl-(3beta,22beta)-3,22-Dihydroxy-12-oleanen-28-oic acid
17-tert-butoxy-19-tert-butyl-9-hydroxy-19-methyl-2-oxo-corynox-16-ene-16-carboxylic acid tert-butyl ester|Speciofolin
Ganoderic acid Me
Ganoderic acid R
(2xi,3xi)-2,3-Dihydroxy-12,18-ursadien-28-oic acid diacetate
Epoxomicin
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061988 - Proteasome Inhibitors
2,3-Dihydroxypropyl (3-docosoxy-2-hydroxypropyl) hydrogen phosphate
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] henicosanoate
[1-hydroxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] pentanoate
[1-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]-3-hydroxypropan-2-yl] heptanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] decanoate
[1-Decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] undecanoate
[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium
[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropyl] (4E,7E)-hexadeca-4,7-dienoate
[1-carboxy-3-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-undecanoyloxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[3-[3-butanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
[1-carboxy-3-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
[3-[3-acetyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
2-[[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2,2,6a,6b,9,9,12a-heptamethyl-4-[(2-methylbutanoyl)oxy]-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid
9-hydroxy-5a,5b,8,8,11a-pentamethyl-6-[(3-methylbut-2-enoyl)oxy]-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
methyl 3-[(2r,3r)-5-methoxy-2,3-dimethyl-6-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-6-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-8-yl]hexanoate
(3e,5z,7r,8s,9s,11z,13z,15s,16r)-16-[(2s,3e)-4-[(6r)-6-ethyl-5-methyl-6h-pyran-2-yl]pent-3-en-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
2,3,6,22,23-pentahydroxy-2,6,10,15,19,23-hexamethyltetracosa-10,14,18-trien-7-yl acetate
2,3,6,10,11-pentahydroxy-2,6,10,15,19,23-hexamethyltetracosa-14,18,22-trien-7-yl acetate
(2e)-6-[3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid
ethyl 3-[(1s,4r,5r,7s,8s,9r,12s,13r)-7-(acetyloxy)-4,8-dimethyl-5-[(1s)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradecan-13-yl]propanoate
[(1r,4s,12s,13r,16r,17s)-17-hydroxy-12-methyl-8-oxapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5(9),6-dien-17-yl]methyl hexadecanoate
(1r,2r,8z,12r,13s,21e,26s,27s)-27-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]-25-oxa-3,16-diazapentacyclo[11.11.3.1¹²,¹⁶.0¹,²⁶.0²,¹²]octacosa-8,21-diene
2,3-dihydroxy-5,12-oleanadien-28-oic acid; (2β,3α)-form,di-ac
{"Ingredient_id": "HBIN004049","Ingredient_name": "2,3-dihydroxy-5,12-oleanadien-28-oic acid; (2\u03b2,3\u03b1)-form,di-ac","Alias": "NA","Ingredient_formula": "C34H50O6","Ingredient_Smile": "NA","Ingredient_weight": "554.76","OB_score": "NA","CAS_id": "142293-75-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8936","PubChem_id": "NA","DrugBank_id": "NA"}